Relationship of time to presentation after onset of upper GI bleeding with patient characteristics and outcomes: a prospective study

Gastrointestinal Endoscopy

Volumn 86, Issue 6, 2017, Pages 1028-1037

  Laine, Loren ^a,b   Laursen, Stig B ^c   Dalton, Harry R ^d   Ngu, Jing H ^e   Schultz, Michael ^f   Stanley, Adrian J ^g  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b VA CONNECTICUT HEALTHCARE SYSTEM   (United States)

^c ODENSE UNIVERSITY HOSPITAL   (Denmark)

^d ROYAL CORNWALL HOSPITAL   (United Kingdom)

^e SINGAPORE GENERAL HOSPITAL   (Singapore)

^f UNIVERSITY OF OTAGO   (New Zealand)

^g GLASGOW ROYAL INFIRMARY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ALBUMIN; ANTICOAGULANT AGENT; HEMOGLOBIN; NONSTEROID ANTIINFLAMMATORY AGENT; SERUM ALBUMIN;

AGED; ARTICLE; BLOOD TRANSFUSION; CLINICAL FEATURE; COFFEE GROUND EMESIS; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; EMERGENCY WARD; FEMALE; HEMOGLOBIN BLOOD LEVEL; HOSPITALIZATION; HUMAN; LENGTH OF STAY; LOW DRUG DOSE; MAJOR CLINICAL STUDY; MALE; MELENA; MORTALITY; MULTICENTER STUDY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROSPECTIVE STUDY; RED-BLOOD EMESIS; UPPER GASTROINTESTINAL BLEEDING; VOMITING; BLOOD; CLINICAL TRIAL; CONFUSION; DUODENUM DISEASE; ESOPHAGUS DISEASE; GLASGOW COMA SCALE; HEMATEMESIS; HEMOSTASIS; LETHARGY; METABOLISM; MIDDLE AGED; PATIENT ATTITUDE; PROGNOSIS; STATISTICS AND NUMERICAL DATA; STOMACH DISEASE; STUPOR; TIME TO TREATMENT;

AGED; BLOOD TRANSFUSION; CONFUSION; DUODENAL DISEASES; ESOPHAGEAL DISEASES; FEMALE; GLASGOW COMA SCALE; HEMATEMESIS; HEMOGLOBINS; HEMOSTASIS, ENDOSCOPIC; HUMANS; LENGTH OF STAY; LETHARGY; MALE; MELENA; MIDDLE AGED; PATIENT ACCEPTANCE OF HEALTH CARE; PROGNOSIS; PROSPECTIVE STUDIES; SERUM ALBUMIN; STOMACH DISEASES; STUPOR; TIME-TO-TREATMENT;

EID: 85019966151     PISSN: 00165107     EISSN: 10976779     Source Type: Journal    
DOI: 10.1016/j.gie.2017.03.1549     Document Type: Article

References (12)

1. Thorne, F.L., Nyhus, L.M., Treatment of massive upper gastrointestinal hemorrhage: a ten-year review. Am Surg 31 (1965), 413–419.
2. Crook, J.N., Gray, L.W. Jr., Nance, F.C., et al. Upper gastrointestinal bleeding. Ann Surg 175 (1972), 771–782.
3. Silverstein, F.E., Gilbert, D.A., Tedesco, F.J., et al. The national ASGE survey on upper gastrointestinal bleeding. II. Clinical prognostic factors. Gastrointest Endosc 27 (1981), 80–93.
4. Schiller, K.R.F., Truelove, S.C., Williams, D.G., Haematemesis and melaena, with special reference to factors influencing the outcome. Br Med J 2 (1970), 7–14.
5. Rockall, T.A., Logan, R.F.A., Devlin, H.B., et al. Risk assessment after acute upper gastrointestinal haemorrhage. Gut 38 (1996), 316–321.
6. Hay, J.A., Lyubashevsky, E., Elashoff, J., et al. Upper gastrointestinal hemorrhage clinical guideline—determining the optimal hospital length of stay. Am J Med 100 (1996), 313–322.
7. Hay, J.A., Maldonado, L., Weingarten, S.R., et al. Prospective evaluation of a clinical guideline recommending hospital length of stay in upper gastrointestinal tract hemorrhage. JAMA 278 (1997), 2151–2156.
8. Stanley, A.J., Laine, L., Dalton, H., et al. Comparison of risk scoring systems for patients presenting with upper gastrointestinal bleeding: international multicentre prospective study. BMJ, 356, 2017, i6432.
9. Peduzzi, P., Concato, Kemper, E., et al. A simulation study of the number of events per variable in logistic regression analysis. J Clin Epidemiol 49 (1996), 1373–1379.
10. Blatchford, O., Murray, W.R., Blatchford, M., A risk score to predict need for treatment for upper-gastrointestinal haemorrhage. Lancet 356 (2000), 1318–1321.
11. Saltzman, J.R., Tabak, Y.P., Hyett, B.H., et al. A simple risk score accurately predicts in-hospital mortality, length of stay, and cost in acute upper GI bleeding. Gastrointest Endosc 74 (2011), 1215–1224.
12. Daniel, W.A. Jr., Egan, S., The quantity of blood required to produce a tarry stool. JAMA, 113, 1939, 2232.